Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Detection of ciprofloxacin resistance in Haemophilus influenzae using nalidixic acid and BSAC methodology.
Brenwald NP, Andrews JM, Jevons G, Wise R. Brenwald NP, et al. Among authors: jevons g. J Antimicrob Chemother. 2003 May;51(5):1311-2. doi: 10.1093/jac/dkg200. Epub 2003 Mar 28. J Antimicrob Chemother. 2003. PMID: 12668572 No abstract available.
Temocillin susceptibility by BSAC methodology.
Andrews JM, Jevons G, Walker R, Ashby J, Fraise AP. Andrews JM, et al. Among authors: jevons g. J Antimicrob Chemother. 2007 Jul;60(1):185-7. doi: 10.1093/jac/dkm179. Epub 2007 Jun 5. J Antimicrob Chemother. 2007. PMID: 17550891 No abstract available.
Disc methods for detecting AmpC {beta}-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae.
Brenwald NP, Jevons G, Andrews J, Ang L, Fraise AP. Brenwald NP, et al. Among authors: jevons g. J Antimicrob Chemother. 2005 Sep;56(3):600-1. doi: 10.1093/jac/dki278. Epub 2005 Aug 8. J Antimicrob Chemother. 2005. PMID: 16087656 No abstract available.
Intrapulmonary penetration of linezolid.
Honeybourne D, Tobin C, Jevons G, Andrews J, Wise R. Honeybourne D, et al. Among authors: jevons g. J Antimicrob Chemother. 2003 Jun;51(6):1431-4. doi: 10.1093/jac/dkg262. Epub 2003 May 13. J Antimicrob Chemother. 2003. PMID: 12746375
An outbreak of a CTX-M-type beta-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum beta-lactamases.
Brenwald NP, Jevons G, Andrews JM, Xiong JH, Hawkey PM, Wise R. Brenwald NP, et al. Among authors: jevons g. J Antimicrob Chemother. 2003 Jan;51(1):195-6. doi: 10.1093/jac/dkg051. J Antimicrob Chemother. 2003. PMID: 12493817 No abstract available.
Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria.
Andrews JM, Ashby JP, Jevons GM, Wise R. Andrews JM, et al. Among authors: jevons gm. J Antimicrob Chemother. 1999 Dec;44(6):819-22. doi: 10.1093/jac/44.6.819. J Antimicrob Chemother. 1999. PMID: 10590284
Susceptibility testing Pasteurella multocida by BSAC standardized methodology.
Andrews JM, Jevons G, Brenwald N, Fraise A; BSAC Working Party on Sensitivity Testing. Andrews JM, et al. Among authors: jevons g. J Antimicrob Chemother. 2004 Nov;54(5):962-4. doi: 10.1093/jac/dkh429. Epub 2004 Sep 16. J Antimicrob Chemother. 2004. PMID: 15375108 No abstract available.
In vitro susceptibility of ertapenem by BSAC standardized methodology.
Andrews JM, Ashby JP, Jevons G, Wise R. Andrews JM, et al. Among authors: jevons g. J Antimicrob Chemother. 2003 Oct;52(4):733-4. doi: 10.1093/jac/dkg430. Epub 2003 Sep 12. J Antimicrob Chemother. 2003. PMID: 12972456 No abstract available.
Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
Harnett SJ, Fraise AP, Andrews JM, Jevons G, Brenwald NP, Wise R. Harnett SJ, et al. Among authors: jevons g. J Antimicrob Chemother. 2004 May;53(5):783-92. doi: 10.1093/jac/dkh180. Epub 2004 Mar 31. J Antimicrob Chemother. 2004. PMID: 15056651
Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
Andrews J, Honeybourne D, Ashby J, Jevons G, Fraise A, Fry P, Warrington S, Hawser S, Wise R. Andrews J, et al. Among authors: jevons g. J Antimicrob Chemother. 2007 Sep;60(3):677-80. doi: 10.1093/jac/dkm242. Epub 2007 Jul 10. J Antimicrob Chemother. 2007. PMID: 17623694
20 results
Jump to page
Feedback